SPY363.67+1.01 0.28%
DIA299.24+0.50 0.17%
IXIC12,205.85+111.44 0.92%

ENDRA Life Sciences Q3 EPS $(0.15) Beats $(0.17) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 67.39 percent increase over losses of $(0.46) per share

· 11/16/2020 16:03
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 67.39 percent increase over losses of $(0.46) per share from the same period last year.